Last reviewed · How we verify

NCT05605080

Hemostatic and Analgesic Effect of Gel Foam and Gauze With Bosmin After Anal Surgery

Completed NA Last updated 22 November 2023
What this trial tests

NA trial testing Gelfoam in Hemorrhoids in 292 participants. Completed in 20 November 2023.

Timeline
7 November 2022
Primary endpoint
30 October 2023
20 November 2023

Quick facts

Lead sponsorTaipei Medical University Shuang Ho Hospital
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment292
Start date7 November 2022
Primary completion30 October 2023
Estimated completion20 November 2023
Sites1 location across Taiwan

Drugs / interventions tested

Conditions studied

Sponsor

Taipei Medical University Shuang Ho Hospital

Who can join

Adults 20 to 85, any sex, with Hemorrhoids or Anal Fistula. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To evaluate the hemostatic and analgesic effect of using gauze with Bosmin or Gelfoam after anal surgery.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Gelfoam

Trials testing the same drug.

Other recruiting trials for Hemorrhoids

Currently open trials in the same condition.

Other Taipei Medical University Shuang Ho Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05605080.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing